Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment

16 Apr 2021

Abstract excerpt

OBJECTIVE Current type 2 diabetes (T2D) management contraindicates intensive glycemia treatment in patients with high cardiovascular disease (CVD) risk and is partially motivated by evidence of harms in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Heterogeneity in response to intensive glycemia treatment has been observed, suggesting potential benefit for some individuals. RESEARCH DESIGN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Diabetes Treatment and Management
Share to Genetic Associations and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33863751
DOI: 10.2337/dc20-2700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia TreatmentPMID 33863751Read ↗

Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank population.Semantic proximity Read ↗

Polygenic risk scores predict diabetic complications and their response to therapySemantic proximity Read ↗

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.Semantic proximity Read ↗

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study.Semantic proximity Read ↗

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.Semantic proximity Read ↗

Phenotypic heterogeneity of type 2 diabetes and risks of complications with a tree-like representation.Semantic proximity Read ↗

Type 2 Diabetes Sub-Phenotypes and Their Association with Cardiovascular Disease Risk: A Multi-Center StudySemantic proximity Read ↗

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.Semantic proximity Read ↗

Precision cardiovascular risk prediction in type 1 diabetes: An IMI2 SOPHIA analysisSemantic proximity Read ↗

Cardiovascular diseases consequences of type 1, type 2 diabetes mellitus and glycemic traits: A Mendelian randomization study.Semantic proximity Read ↗

Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.Semantic proximity Read ↗

Clustering of adult-onset diabetes into novel subgroups guides therapy and improves prediction of outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.